Dapagliflozin, an SGLT2 inhibitor, for diabetes

Lancet. 2010 Jun 26;375(9733):2196-8. doi: 10.1016/S0140-6736(10)60749-0.
No abstract available

Publication types

  • Comment

MeSH terms

  • Benzhydryl Compounds
  • Blood Glucose / analysis
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Glucosides / therapeutic use*
  • Glycosuria
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Benzhydryl Compounds
  • Blood Glucose
  • Glucosides
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors
  • dapagliflozin